- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Trevi Therapeutics Stock (NASDAQ:TRVI), Quotes and News Summary
Trevi Therapeutics Stock (NASDAQ: TRVI)
| Day Range- - - | 52 Wk Range0.46 - 4.68 | Open / Close- / - | Float / Outstanding27.1M / 44.1M |
| Vol / Avg.- / 1.5M | Mkt Cap75.8M | P/E- | 50d Avg. Price3.29 |
| Div / Yield- | Payout Ratio- | Total Float27.1M | EPS-0.14 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-09 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.140 | 0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Trevi Therapeutics Questions & Answers
You can purchase shares of Trevi Therapeutics (NASDAQ: TRVI) through any online brokerage.
Other companies in Trevi Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
The latest price target for Trevi Therapeutics (NASDAQ: TRVI) was reported by Needham on Thursday, June 30, 2022. The analyst firm set a price target for 10.00 expecting TRVI to rise to within 12 months (a possible 481.40% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $1.72 last updated September 28, 2022, 8:00 PM UTC.
There are no upcoming dividends for Trevi Therapeutics.
Trevi Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Trevi Therapeutics.
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.